Initial experience of tofacitinib for treating refractory moderate-to-severe ulcerative colitis

Ulcerative colitis (UC) is an incurable, chronic inflammatory disease of the large bowel whose etiology and pathogenesis have not yet been comprehensively explained. Tofacitinib is a small molecule Janus kinase inhibitor that was introduced for treating refractory UC. We aimed to examine the efficac...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Masanao, Yamamura, Takeshi, Maeda, Keiko, Sawada, Tsunaki, Mizutani, Yasuyuki, Ishikawa, Eri, Ishikawa, Takuya, Kakushima, Naomi, Furukawa, Kazuhiro, Ohno, Eizaburo, Kawashima, Hiroki, Honda, Takashi, Ishigami, Masatoshi, Fujishiro, Mitsuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nagoya University 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971039/
https://www.ncbi.nlm.nih.gov/pubmed/35392018
http://dx.doi.org/10.18999/nagjms.84.1.169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971039/
https://www.ncbi.nlm.nih.gov/pubmed/35392018
http://dx.doi.org/10.18999/nagjms.84.1.169

Ejemplares similares